企業プロフィール
Sensei Biotherapeutics 株価・ニュース・カタリスト
- ティッカー:
- SNSE
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
13.85 USD (+6.54%)
終値
最終更新: 2026年6月15日
21.6M USD
時価総額
株価変動の要因
Current closing-price context is not available for SNSE.
企業概要
事業概要
Sensei Biotherapeutics is an immuno-oncology company focused on activating the immune system against cancer. Its platform aims to create differentiated cancer treatments through immune modulation.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Sensei sits in specialty oncology biotechnology.
ビジネスモデルの特徴
The company depends on clinical data, immune-mechanism validation, and the ability to build a durable cancer franchise.
バイオ業界での位置付け
Sensei is a catalyst-driven immuno-oncology name whose stock responds to early clinical and translational progress.
今後のカタリスト
- The cleaner way to frame Sensei Biotherapeutics right now is around its latest development priorities. The most useful line from the latest update is First patient dosed in Phase 1b/2 trial of PIKTOR in HR+/HER2- advanced breast cancer Topline Phase 2 data in patients with advanced endometrial cancer expected in second half.... That should keep the program at the center of the company narrative for now.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。